Find Veliparib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 912444-00-9, Abt-888, Abt 888, Abt-888 (veliparib), Veliparib free base, Abt888
Molecular Formula
C13H16N4O
Molecular Weight
244.29  g/mol
InChI Key
JNAHVYVRKWKWKQ-CYBMUJFWSA-N
FDA UNII
01O4K0631N

Veliparib
Veliparib is a poly(ADP-ribose) polymerase (PARP) -1 and -2 inhibitor with chemosensitizing and antitumor activities. With no antiproliferative effects as a single agent at therapeutic concentrations, ABT-888 inhibits PARPs, thereby inhibiting DNA repair and potentiating the cytotoxicity of DNA-damaging agents. PARP nuclear enzymes are activated by DNA single or double strand breaks, resulting in the poly(ADP-ribosyl)ation of other nuclear DNA binding proteins involved in DNA repair; poly(ADP-ribosyl)ation contributes to efficient DNA repair and to survival of proliferating cells exposed to mild genotoxic stresses as induced by as oxidants, alkylating agents or ionizing radiation.
1 2D Structure

Veliparib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide
2.1.2 InChI
InChI=1S/C13H16N4O/c1-13(6-3-7-15-13)12-16-9-5-2-4-8(11(14)18)10(9)17-12/h2,4-5,15H,3,6-7H2,1H3,(H2,14,18)(H,16,17)/t13-/m1/s1
2.1.3 InChI Key
JNAHVYVRKWKWKQ-CYBMUJFWSA-N
2.1.4 Canonical SMILES
CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N
2.1.5 Isomeric SMILES
C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N
2.2 Other Identifiers
2.2.1 UNII
01O4K0631N
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide

2. 2-(2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide

3. Abt 888

4. Abt-888

5. Abt888

2.3.2 Depositor-Supplied Synonyms

1. 912444-00-9

2. Abt-888

3. Abt 888

4. Abt-888 (veliparib)

5. Veliparib Free Base

6. Abt888

7. (r)-2-(2-methylpyrrolidin-2-yl)-1h-benzo[d]imidazole-4-carboxamide

8. 2-[(2r)-2-methylpyrrolidin-2-yl]-1h-benzimidazole-4-carboxamide

9. 2-[(2r)-2-methyl-2-pyrrolidinyl]-1h-benzimidazole-7-carboxamide

10. Chebi:62880

11. 2-[(r)-2-methylpyrrolidin-2-yl]-1h-benzimidazole-4-carboxamide

12. Parp-1 Inhibitor Abt-888

13. 912444-00-9 (free Base)

14. 01o4k0631n

15. 2-[(2r)-2-methylpyrrolidin-2-yl]-1h-benimidazole-4-

16. (2r)-2-(7-carbamoyl-1h-benzimidazol-2-yl)-2-methylpyrrolidinium

17. 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide

18. Veliparib (abt-888)

19. (r)-2-(2-methylpyrrolidin-2-yl)-1h-benimidazole-4-carboxamide (veliparib)

20. 2-((2r)-2-methyl-2-pyrrolidinyl)-1h-benzimidazole-7-carboxamide

21. 2-((2r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide

22. Nsc-737664

23. Veliparib [usan:inn]

24. Mfcd16661059

25. Unii-01o4k0631n

26. 78p

27. Veliparib [inn]

28. Veliparib [jan]

29. Veliparib [usan]

30. Abt888 (free Base)

31. (r)-2-(2-methylpyrrolidin-2-yl)-1h-benzo[d]imidazole-7-carboxamide

32. Veliparib [who-dd]

33. Benzimidazole Carboxamide, 3a

34. Mls006010184

35. Veliparib (jan/usan/inn)

36. Schembl422318

37. Chembl506871

38. Gtpl7417

39. Bdbm27135

40. Abt-695

41. Dtxsid90238456

42. Ex-a001

43. Bdbm209932

44. Veliparib (abt-888 Hydrochloride)

45. 2-[(2r)-2-methylpyrrolidin-2-yl]-1h-1,3-benzodiazole-4-carboxamide

46. Nsc737664

47. Nsc752840

48. S1004

49. Zinc84610155

50. Akos015951440

51. Akos017343746

52. Ccg-264771

53. Cs-0076

54. Db07232

55. Ex-7209

56. Nsc 737664

57. Nsc-752840

58. Sb16480

59. Ncgc00250404-01

60. Ncgc00250404-15

61. Ac-23330

62. As-19397

63. Hy-10129

64. Smr004701290

65. Abt-888 (veliparib, Nsc 737664)

66. A24888

67. D09692

68. A 861695

69. A-861695

70. J-505211

71. Q7919041

72. Brd-k87142802-001-02-7

73. 1h-benzimidazole-4-carboxamide, 2-((2r)-2-methyl-2-pyrrolidinyl)-

74. 2-[(2r)-2-methylpyrrolidin-2-yl]-1h-benimidazole-4-carboxamide

75. 2-[(2r)-2-methylpyrrolidin-2-yl]-1h-benzimidazole-7-carboxamide

76. 2-[(r)-2-methylpyrrolidin-2-yl]-1h-benzimidazole-4-carboxamide;

77. 1h-benzimidazole-7-carboxamide, 2-((2r)-2-methyl-2-pyrrolidinyl)-

2.4 Create Date
2006-12-11
3 Chemical and Physical Properties
Molecular Weight 244.29 g/mol
Molecular Formula C13H16N4O
XLogP30.5
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count3
Rotatable Bond Count2
Exact Mass244.13241115 g/mol
Monoisotopic Mass244.13241115 g/mol
Topological Polar Surface Area83.8 Ų
Heavy Atom Count18
Formal Charge0
Complexity348
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Treatment of fallopian tube cancer , Treatment of ovarian cancer , Treatment of peritoneal carcinoma


Treatment of lung carcinoma (small cell and non-small cell carcinoma)


Treatment of breast cancer


Treatment of high-grade glioma


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Poly(ADP-ribose) Polymerase Inhibitors

Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES. (See all compounds classified as Poly(ADP-ribose) Polymerase Inhibitors.)


5.2 ATC Code

L - Antineoplastic and immunomodulating agents

L01 - Antineoplastic agents

L01X - Other antineoplastic agents

L01XK - Poly (adp-ribose) polymerase (parp) inhibitors

L01XK05 - Veliparib


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty